Point-of-Care Testing
|5+ min read
Ebola Outbreaks: The Critical Role of Diagnostics, Laboratory Readiness, and Global Preparedness
Amid the 2026 Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, laboratory leaders are confronting persistent challenges in diagnostics, surveillance, and global outbreak readiness
Updated |3 min read
How Ultra-Rapid Molecular Diagnostics Are Reshaping the Clinical Laboratory
Ultra-rapid, CLIA-waived molecular testing is reshaping clinical laboratory operations while expanding near-patient diagnostic care
|5 min read
Syphilis Cases in Expectant Mothers Have Dramatically Risen Since the Pandemic—Here’s What’s Driving the Trend
A pregnant mother with untreated syphilis can pass it to the unborn fetus
|3 min read
Polydrug Use and Diagnostic Challenges in Emergency Departments
Rising polydrug use in the US is intensifying pressure on emergency departments to deliver rapid, reliable diagnostic data to guide overdose care
|2 min read
New Portable TB Test Matches Lab Accuracy in Minutes
MiniDock MTB, a battery-powered molecular TB test, delivers accurate results in under 30 minutes without lab equipment, expanding access in low-resource settings
|2 min read
QuidelOrtho Acquires LEX Diagnostics, Expands Ultra-Fast PCR Platform
QuidelOrtho has acquired LEX Diagnostics, adding a CLIA-waived multiplex RT-PCR system delivering respiratory results in less than 10 minutes
|2 min read
Labcorp Launches FDA-Cleared 10-Minute Rapid Fentanyl Urine Test
New point-of-care test detects fentanyl metabolite norfentanyl, extending detection up to 48 hours to support faster clinical decisions in acute care settings
|2 min read
Collaboration Tackles Critical Gaps in US STI Diagnostics
Intermountain Health’s support accelerates Testmate’s deployment of rapid molecular tests where patients often face delayed results or no access to lab-quality testing
|1 min read
Advancing Syphilis Detection Through Rapid Testing
Learn how rapid testing initiatives are addressing diagnostic delays in pregnancy and supporting earlier intervention against congenital syphilisSponsored by
|2 min read
'Reemerging Threats, Reimagined Strategies'
The Today's Clinical Lab 2025 Pathogen Detection & Infectious Disease print issue features smarter diagnostics, reemerging threats, and lab-driven strategies for tackling sepsis, measles, and C. difficile infections
|4 min read
Challenges and Advances in Sepsis Detection
FDA-approved tests like Intellisep and TriVerity™ demonstrate potential for early sepsis diagnosis
|3 min read
Bridging the Sepsis Diagnosis Gap: How Host Response Diagnostics Are Changing the Front Line
Sepsis remains elusive without a definitive test. A breakthrough in host response diagnostics may finally close the gap
|3 min read
